Align Technology misses Q2 revenue estimates, lowers FY23 guidance.

Tuesday, Sep 2, 2025 10:06 am ET1min read

• Pomerantz LLP investigates Align Technology securities fraud claims • Align misses Q2 revenue estimates, lowers Q3 and FY growth expectations • Company cites economic uncertainty and spending hesitancy for demand decline • Investors advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 • Class action lawsuit available for those who want to join

Align Technology Inc. (ALGN) has been the subject of a securities fraud investigation by Pomerantz LLP, following the company's second-quarter (Q2) 2025 financial results, which fell short of both analyst expectations and its own forecasts. The investigation, which was announced on August 23, 2025, is part of a broader probe into potential securities law violations by the company.

Align Technology reported revenues of approximately $1.01 billion for Q2 2025, which was significantly below consensus estimates. The company also revised its revenue guidance for the third quarter (Q3) and full year, citing economic uncertainty and spending hesitancy as reasons for the decline in demand for its aligners. The stock price dropped by nearly 37% on July 31, 2025, following the announcement of the Q2 results and the revised guidance.

The company has cited economic uncertainty and spending hesitancy as the primary reasons for the decline in demand for its aligners. Align Technology has stated that it expects to continue investing in next-generation products to drive long-term adoption, despite the current challenges.

Align Technology will be presenting at several financial conferences, including the 2025 Wells Fargo Healthcare Conference, Morgan Stanley's 23rd Annual Global Healthcare Conference, and the Baird Global Healthcare Conference. The presentations will be webcast live via the company's website and will feature John Morici, EVP Global Finance and CFO, and Shirley Stacy, VP Finance, Global Communications and IRO.

Investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, for more information about the investigation. A class action lawsuit is also available for those who wish to join.

References:
[1] https://www.globenewswire.com/news-release/2025/08/23/3138106/0/en/ALIGN-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Align-Technology-Inc-on-Behalf-of-Align-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html
[2] https://www.globenewswire.com/news-release/2025/08/25/3138648/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Align-Technology-Inc-ALGN.html

Comments



Add a public comment...
No comments

No comments yet